In a further sign that marijuana has attained legitimacy on Wall Street, Merrill Lynch has initiated coverage on the sector in recent months – and analysts at the firm are particularly optimistic about the prospects of five cannabis companies, whose stocks they rate as Buy. For these five marijuana stocks – including what could be “an off-the-radar play for investors looking for a marijuana play with lower name recognition” – CLICK HERE.